GLP-1 RAs improve glycemic control, promote cardiovascular and renal protection, and reduce all-cause mortality [2, 3]
The breakdown shows 14.3% of patients have minimal retention, 44.3% show moderate amounts, and 41.4% have large quantities [3]
Risks of compounded GLP-1s include: Improper prescriptions Dosing errors Lack of standardization Contamination Misbranding of products The FDA is currently concerned with an increase in cases of unapproved compounded semaglutide and tirzepatide marketed in the U.S., encouraging consumers to be cautious of where they are getting their medications from
New and expanded recommendations include: Annual screening for anxiety and diabetes distress Referral when distress exceeds what the visit can address Routine screening for sleep health Avoidance of tobacco and vaping with combined counseling and pharmacotherapy These updates acknowledge that physiology responds to behavior, sleep, and mental health
Detail pricing can be found on the Reflect Wellness & Aesthetics Price List CLICK HERE TO ACCESS THE PRICE LIST First-Time Reflect Wellness & Weight Loss Customer, Returning Reflect Wellness Customer, Existing Weight Loss Customer Transferring from Another Provider 1st (.25mg), 2nd (.50mg), 3rd (1mg), 4th (1.5mg), 5th (2mg), 6th (2.5mg)
